
    
      Multi-Center, Open-Label, Randomized, Two treatment, Parallel, Single period, Multiple-Dose,
      Steady state, Global Bioequivalence study of Amphotericin B Liposome for Injection 50mg /vial
      of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) Liposome for Injection 50mg/vial
      of Astellas Pharma US, inc. in patients with Visceral Leishmaniasis under fed
      condition.Sufficient number of patients will be enrolled to have 140 evaluable patients. (90
      to 100 patients from India and 40 to 50 patients from Bangladesh).
    
  